Title : Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSĂ© phase II trial.

Pub. Date : 2019 Dec 1

PMID : 31584608






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSe phase II trial. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens